knowledge -WSS

knowledge

author：focus 2025-09-30 23:40:29 - browse：5181

Adobe

More than a year ago, Kaiser Permanente made waves when it said it was creating a new, sprawling entity of nonprofit hospitals and doctors with Geisinger as its first takeover — the latest example of health care companies bulking up in an already highly consolidated industry.

Nothing has happened since then, at least publicly. Geisinger’s 10 hospitals and 1,700 employed physicians are now officially part of the group, known as Risant Health. Kaiser, which is both a health insurance company and a network of providers, said it wants to add at least five to six more health systems by 2028.

Those other organizations are still a mystery. But recent financial reports show a handful of systems that have been on the same shaky trajectory as Geisinger and could find themselves in Kaiser’s crosshairs. Patients and local communities have a lot at stake if their health system gets gobbled up by Kaiser; it’s still unclear how this unique structure will alter costs or quality of care.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Regeneron agrees to White House price limits on anti

WSS

White House touts steps to stem shortages of cancer treatments

Boston hospital trains restaurant workers on naloxone for overdoses

Free medical tuition alone isn't enough to close gaps in primary care

Long Covid needs a new name — and a new frame

ALS treatment from Biogen, Ionis fails in study

Supreme Court to hear if Covid misinformation is protected speech

explore

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

Trump demands the U.S. pay no more for drugs than other countries … again

Regeneron agrees to White House price limits on anti

Novavax promises a turnaround & Lilly roils the obesity market

The White House hikes tariffs on plastic syringes made in China

Trump demands the U.S. pay no more for drugs than other countries … again

White House touts steps to stem shortages of cancer treatments

23andMe had bad news about my health. I wish a person had delivered it

WuXi Biologics beefs up its lobbying operation

Apple is now the first public company to be valued at $3 trillion

What a koala virus tells us about the human genome

explore

Regeneron agrees to White House price limits on anti

HHS suspends federal funding for EcoHealth Alliance

What a koala virus tells us about the human genome

Oak Street deal isn't the answer to health care's woes

Fertility clinic egg and embryo storage is a disaster

HHS suspends federal funding for EcoHealth Alliance

hotspot

leisure time

Wikipedia

focus